← Human Trials & Peer-Reviewed Studies
A 12-week double-blind randomised controlled trial investigating the effect of dietary supplementation with /d vitamin D in adults with asthma.
Plain-language guide to PMID 38751303 (2024): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 32 participants.
Key Facts
- PMID
- 38751303
- Journal
- The British journal of nutrition
- Year
- 2024
- Study type
- Randomized Controlled Trial
- Authors
- Watkins S et al. (3 authors)
- DOI
- 10.1017/S0007114524000953
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
Previous randomised controlled trials investigating the effect of vitamin D supplementation have mainly focused on children with asthma.
The primary outcome of the study was lung function measured by the ratio of FEV1:FVC (effect size 2·5) with secondary outcomes including asthma symptoms and inflammatory biomarkers.
Who Took Part
The abstract describes 32 participants taking part.
The age groups tagged for this paper are young adults, adults and middle-aged adults, both men and women.
How the Study Was Run
The design is described as randomized, double-blind and placebo-controlled.
The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
As a double-blind Vitamin D, K2, Magnesium and Zinc study, the assignments were hidden from both participants and investigators until the end.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
What Was Measured
The primary outcome of the study was lung function measured by the ratio of FEV1:FVC (effect size 2·5) with secondary outcomes including asthma symptoms and inflammatory biomarkers.
PubMed files the paper under topics including Asthma, Dietary Supplements, Vitamin D, Vitamin D Deficiency, Biomarkers, Cholecalciferol and Lung.
The authors tagged it with the keywords Dietary supplementation and Lung function.
What This Means in Plain Language
The paper is a randomized, double-blind and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc in 32 participants.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
The publication is from 2024 (The British journal of nutrition), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.